Exosomes from young healthy human plasma promote functional recovery from intracerebral hemorrhage via counteracting ferroptotic injury

Wenqin Yang,Ning Ding,Ran Luo,Qian Zhang,Zhenhua Li,Fengchun Zhao,Shuixian Zhang,Xuyang Zhang,Tengyuan Zhou,Haomiao Wang,Long Wang,Shengli Hu,Guixue Wang,Hua Feng,Rong Hu
DOI: https://doi.org/10.1016/j.bioactmat.2023.03.007
IF: 18.9
2023-03-25
Bioactive Materials
Abstract:Highlights • Young Human plasma-derived exosomes alleviate brain damage and promote functional recovery after intracerebral hemorrhage. • Exosome-encapsulated miR-25-3p mediates the effect of young plasma-derived exosomes via counteracting ferroptosis. • MiR-25-3p counteracts ferroptotic injury by modulating p53/SLC7A11/GPX4 signaling pathway. Intracerebral hemorrhage (ICH), as a type of life-threatening and highly disabled disease, has limited therapeutic approaches. Here, we show that exosomes derived from young healthy human plasma exhibiting typical exosomes features could facilitate functional recovery of ICH mice. When these exosomes are intraventricularly delivered into the brain after ICH, they mainly distribute around the hematoma and could be internalized by neuronal cells. Strikingly, exosomes administration markedly enhanced the behavioral recovery of ICH mice through reducing brain injury and cell ferroptosis. MiRNA sequencing revealed that microRNA-25-3p (miR-25-3p) was differentially expressed miRNA in the exosomes from young healthy human plasma, compared with exosomes from the old control. Importantly, miR-25-3p mimicked the treatment effect of exosomes on behavioral improvement, and mediated the neuroprotective effect of exosomes against ferroptosis in ICH. Furthermore, luciferase assay and western blotting data illustrated that P53 as assumed the role of a downstream effector of miR-25-3p, thereby regulating SLC7A11/GPX4 pathway to counteract ferroptosis. Taken together, these findings firstly reveal that exosomes from young healthy human plasma improve functional recovery through counteracting ferroptotic injury by regulating P53/SLC7A11/GPX4 axis after ICH. Given the easy availability of plasma exosomes, our study provides a potent therapeutic strategy for ICH patients with quick clinical translation in the near future. Graphical abstract Schematics illustrating the potential mechanism underpinning the neuroprotection of exosomes from young plasma against ferroptosis after ICH. Plasma-derived exosomes from healthy young man carry miR-25-3p, which is uptaken by neural cells after cerebral hemorrhage. Exosomes encapsulated miR-25-3p specifically downregulates P53 via inducing P53 mRNA degradation, thereby activates SLC7A11/GPX4 signaling pathway to counteract ferroptosis and promote functional recovery after intracerebral hemorrhage. Download : Download high-res image (319KB) Download : Download full-size image
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?